COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 142 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $509,603 | +28.6% | 22,801 | +23.6% | 0.00% | – |
| Q2 2023 | $396,362 | -98.4% | 18,444 | -98.5% | 0.00% | -100.0% |
| Q4 2020 | $25,145,000 | -27.5% | 1,255,371 | -24.6% | 0.01% | -35.3% |
| Q3 2020 | $34,684,000 | +19.2% | 1,665,872 | +0.1% | 0.02% | +13.3% |
| Q2 2020 | $29,099,000 | -2.6% | 1,664,663 | -9.0% | 0.02% | -25.0% |
| Q1 2020 | $29,881,000 | -18.0% | 1,829,772 | +3.4% | 0.02% | +5.3% |
| Q4 2019 | $36,429,000 | +70.3% | 1,770,152 | -5.0% | 0.02% | +58.3% |
| Q3 2019 | $21,387,000 | -12.4% | 1,862,971 | +0.4% | 0.01% | -7.7% |
| Q2 2019 | $24,404,000 | -12.1% | 1,855,845 | +1.2% | 0.01% | -13.3% |
| Q1 2019 | $27,764,000 | -11.8% | 1,833,838 | -0.0% | 0.02% | -21.1% |
| Q4 2018 | $31,495,000 | +21.4% | 1,834,289 | +4.3% | 0.02% | +46.2% |
| Q3 2018 | $25,935,000 | -23.0% | 1,759,506 | +24.6% | 0.01% | -23.5% |
| Q2 2018 | $33,686,000 | -10.3% | 1,412,442 | -3.9% | 0.02% | -10.5% |
| Q1 2018 | $37,535,000 | +34.5% | 1,469,119 | -2.8% | 0.02% | +46.2% |
| Q4 2017 | $27,907,000 | +19.1% | 1,511,775 | -32.3% | 0.01% | +18.2% |
| Q3 2017 | $23,426,000 | -15.0% | 2,233,147 | +1.3% | 0.01% | -21.4% |
| Q2 2017 | $27,569,000 | +22.8% | 2,203,781 | -1.2% | 0.01% | +27.3% |
| Q1 2017 | $22,446,000 | -19.8% | 2,231,203 | +24.1% | 0.01% | -21.4% |
| Q4 2016 | $27,994,000 | +60.2% | 1,797,902 | +98.2% | 0.01% | +55.6% |
| Q3 2016 | $17,469,000 | +63.1% | 907,034 | +0.4% | 0.01% | +50.0% |
| Q2 2016 | $10,708,000 | -28.9% | 903,602 | +8.9% | 0.01% | -25.0% |
| Q1 2016 | $15,057,000 | +68.8% | 829,599 | +155.8% | 0.01% | +60.0% |
| Q4 2015 | $8,919,000 | +20.3% | 324,300 | -3.3% | 0.01% | +25.0% |
| Q3 2015 | $7,413,000 | +25.7% | 335,300 | +1.4% | 0.00% | +33.3% |
| Q2 2015 | $5,898,000 | – | 330,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 2,606,500 | $51,452,000 | 1.44% |
| Camber Capital Management LP | 2,000,000 | $39,480,000 | 1.22% |
| Eventide Asset Management | 2,629,593 | $51,908,000 | 0.68% |
| GREAT POINT PARTNERS LLC | 121,342 | $2,395,000 | 0.56% |
| RICE HALL JAMES & ASSOCIATES, LLC | 753,038 | $14,865,000 | 0.55% |
| Values First Advisors, Inc. | 41,773 | $825,000 | 0.53% |
| CLARK ESTATES INC/NY | 183,800 | $3,628,000 | 0.52% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 710,398 | $14,023,000 | 0.48% |
| EMERALD ADVISERS, LLC | 590,256 | $11,652,000 | 0.42% |
| ACORN FINANCIAL ADVISORY SERVICES INC /ADV | 68,812 | $1,358,000 | 0.42% |